Ratings by TD Cowen (Brendan Smith)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2026 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2026 | Ginkgo Bioworks Holdings Inc | DNA | Downgrade | Hold (Buy) |
9.37 (7.03) |
-24.97% | Details | |
| 7/23/2026 | BioLife Solutions | BLFS | Downgrade | Hold (Buy) |
29.19 (35.92) |
23.06% | Details | |
| 7/15/2026 | Evotec | EVO | Downgrade | Hold (Buy) |
2.43 (1.90) |
-21.81% | Details | |
| 6/15/2026 | Twist Bioscience | TWST | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2026 | Twist Bioscience | TWST | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2026 | West Pharmaceutical | WST | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2026 | Passage Bio Inc. | PASG | Downgrade | Hold (Buy) |
6.25 (4.61) |
-26.24% | Details | |
| 4/13/2026 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2026 | Simulations Plus | SLP | Maintain | Hold (N/A) |
|
Details | ||
| 2/26/2026 | Certara Inc. | CERT | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2026 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | Azenta, Inc. | AZTA | Maintain | Hold (N/A) |
|
Details | ||
| 1/13/2026 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2026 | Twist Bioscience | TWST | Maintain | (N/A) |
|
Details | ||
| 1/8/2026 | Simulations Plus | SLP | Maintain | (N/A) |
|
Details | ||
| 1/8/2026 | Schrodinger | SDGR | Maintain | (N/A) |
|
Details | ||
| 1/8/2026 | Halozyme Therapeutics | HALO | Maintain | (N/A) |
|
Details | ||
| 1/8/2026 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | (N/A) |
|
Details | ||
| 1/8/2026 | Cytek Biosciences Inc | CTKB | Maintain | (N/A) |
|
Details | ||
| 1/8/2026 | Azenta, Inc. | AZTA | Maintain | (N/A) |
|
Details | ||
| 11/7/2025 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | (N/A) |
|
Details | ||
| 11/7/2025 | Codexis, Inc. | CDXS | Maintain | (N/A) |
|
Details | ||
| 11/7/2025 | BioLife Solutions | BLFS | Maintain | (N/A) |
|
Details | ||
| 11/7/2025 | Alpha Teknova Inc. | TKNO | Maintain | (N/A) |
|
Details | ||
| 10/29/2025 | West Pharmaceutical | WST | New Coverage | Buy (N/A) |
283.49 (342.63) |
20.86% | Details | |
| 10/8/2025 | OmniAb, Inc. | OABI | Maintain | (N/A) |
|
Details | ||
| 10/8/2025 | Evotec | EVO | Maintain | (N/A) |
|
Details | ||
| 10/8/2025 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | (N/A) |
|
Details | ||
| 10/8/2025 | Azenta, Inc. | AZTA | Maintain | (N/A) |
|
Details | ||
| 9/30/2025 | Simulations Plus | SLP | New Coverage | Hold (N/A) |
14.90 (18.43) |
23.69% | Details | |
| 8/8/2025 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2025 | Novavax | NVAX | Maintain | Hold (N/A) |
|
Details | ||
| 6/10/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2025 | Cytek Biosciences Inc | CTKB | Downgrade | Hold (Buy) |
3.79 (4.69) |
23.75% | Details | |
| 5/6/2025 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2025 | Azenta, Inc. | AZTA | Maintain | Hold (N/A) |
|
Details | ||
| 2/28/2025 | Recursion Pharmaceuticals | RXRX | Maintain | Hold (N/A) |
|
Details | ||
| 2/28/2025 | Cytek Biosciences Inc | CTKB | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Codexis, Inc. | CDXS | Maintain | Hold (N/A) |
|
Details | ||
| 2/27/2025 | Certara Inc. | CERT | New Coverage | Buy (N/A) |
12.33 (8.28) |
-32.85% | Details | |
| 2/27/2025 | Azenta, Inc. | AZTA | New Coverage | Hold (N/A) |
47.04 (31.73) |
-32.55% | Details | |
| 2/26/2025 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2025 | Alpha Teknova Inc. | TKNO | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2025 | Ginkgo Bioworks Holdings Inc | DNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2024 | Exscientia PLC | EXAI | Maintain | Hold (N/A) |
|
Details | ||
| 10/18/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2024 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2024 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2024 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | Exscientia PLC | EXAI | Downgrade | Hold (Buy) |
4.50 (4.84) |
7.56% | Details | |
| 8/7/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2024 | Exscientia PLC | EXAI | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2024 | Exscientia PLC | EXAI | New Coverage | Buy (N/A) |
5.71 (4.50) |
-21.19% | Details | |
| 6/27/2024 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | Novavax | NVAX | Maintain | Hold (N/A) |
|
Details | ||
| 2/29/2024 | Halozyme Therapeutics | HALO | New Coverage | Buy (N/A) |
39.69 (109.66) |
176.29% | Details | |
| 7/21/2023 | Arrowhead Pharma | ARWR | New Coverage | Buy (N/A) |
34.82 (85.37) |
145.18% | Details | |
| 12/5/2022 | Denali Therapeutics Inc. | DNLI | New Coverage | Buy (N/A) |
32.63 (22.85) |
-29.97% | Details |
